Pharmaceuticals Top 5 Emerging Markets Industry Guide 2015-2024
Summary
The Emerging 5 Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2015-19, and forecast to 2024). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Essential resource for top-line data and analysis covering the emerging five pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.
Key Highlights
- These countries contributed $214.1 billion to the global pharmaceuticals industry in 2019, with a compound annual growth rate (CAGR) of 6.6% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $291.7 billion in 2024, with a CAGR of 6.4% over the 2019-24 period.
- Within the pharmaceuticals industry, China is the leading country among the top 5 emerging nations, with market revenues of $142.6 billion in 2019. This was followed by India and Brazil with a value of $32.5 and $29.6 billion, respectively.
- China is expected to lead the pharmaceuticals industry in the top five emerging nations, with a value of $206.3 billion in 2024, followed by India and Brazil with expected values of $38.6 and $35.7 billion, respectively.
Scope- Save time carrying out entry-level research by identifying the size, growth, and leading players in the emerging five pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five pharmaceuticals market
- Leading company profiles reveal details of key pharmaceuticals market players’ emerging five operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the emerging five pharmaceuticals market with five year forecasts
- Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country
Reasons to Buy- What was the size of the emerging five pharmaceuticals market by value in 2019?
- What will be the size of the emerging five pharmaceuticals market in 2024?
- What factors are affecting the strength of competition in the emerging five pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the emerging five pharmaceuticals market?
- 1 Introduction
- 1.1. What is this report about?
- 1.2. Who is the target reader?
- 1.3. How to use this report
- 1.4. Definitions
- 2 Top 5 Emerging Countries Pharmaceuticals
- 2.1. Industry Outlook
- 3 Pharmaceuticals in South Africa
- 3.1. Market Overview
- 3.2. Market Data
- 3.3. Market Segmentation
- 3.4. Market outlook
- 3.5. Five forces analysis
- 3.6. Macroeconomic Indicators
- 4 Pharmaceuticals in Brazil
- 4.1. Market Overview
- 4.2. Market Data
- 4.3. Market Segmentation
- 4.4. Market outlook
- 4.5. Five forces analysis
- 4.6. Macroeconomic Indicators
- 5 Pharmaceuticals in China
- 5.1. Market Overview
- 5.2. Market Data
- 5.3. Market Segmentation
- 5.4. Market outlook
- 5.5. Five forces analysis
- 5.6. Macroeconomic Indicators
- 6 Pharmaceuticals in India
- 6.1. Market Overview
- 6.2. Market Data
- 6.3. Market Segmentation
- 6.4. Market outlook
- 6.5. Five forces analysis
- 6.6. Macroeconomic Indicators
- 7 Pharmaceuticals in Mexico
- 7.1. Market Overview
- 7.2. Market Data
- 7.3. Market Segmentation
- 7.4. Market outlook
- 7.5. Five forces analysis
- 7.6. Macroeconomic Indicators
- 8 Company Profiles
- 8.1. Adcock Ingram Holdings Ltd
- 8.2. Aspen Pharmacare Holdings Ltd
- 8.3. Sanofi SA
- 8.4. Novartis AG
- 8.5. EMS Sigma Pharma
- 8.6. Ache Laboratorios Farmaceuticos SA
- 8.7. Yangtze River Pharmaceutical Group
- 8.8. Shanghai Pharmaceutical Co Ltd
- 8.9. Guangzhou Pharmaceuticals Corp
- 8.10. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
- 8.11. Lupin Ltd
- 8.12. Sun Pharmaceutical Industries Inc
- 8.13. Dr. Reddy's Laboratories Limited
- 8.14. Aurobindo Pharma Ltd
- 8.15. Bayer AG
- 8.16. Pfizer Inc.
- 8.17. Merck & Co., Inc.
- 9 Appendix
- 9.1. Methodology
- 9.2. About MarketLine
- List of Tables
- Table 1: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2015-24
- Table 2: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2015-19
- Table 3: Top 5 emerging countries pharmaceuticals industry forecast, revenue ($bn), 2019-24
- Table 4: South Africa pharmaceuticals market value: $ billion, 2015-19
- Table 5: South Africa pharmaceuticals market geography segmentation: $ billion, 2019
- Table 6: South Africa pharmaceuticals market share: % share, by value, 2019
- Table 7: South Africa pharmaceuticals market value forecast: $ billion, 2019-24
- Table 8: South Africa size of population (million), 2015-19
- Table 9: South Africa gdp (constant 2005 prices, $ billion), 2015-19
- Table 10: South Africa gdp (current prices, $ billion), 2015-19
- Table 11: South Africa inflation, 2015-19
- Table 12: South Africa consumer price index (absolute), 2015-19
- Table 13: South Africa exchange rate, 2015-19
- Table 14: Brazil pharmaceuticals market value: $ billion, 2015-19
- Table 15: Brazil pharmaceuticals market geography segmentation: $ billion, 2019
- Table 16: Brazil pharmaceuticals market share: % share, by value, 2019
- Table 17: Brazil pharmaceuticals market value forecast: $ billion, 2019-24
- Table 18: Brazil size of population (million), 2015-19
- Table 19: Brazil gdp (constant 2005 prices, $ billion), 2015-19
- Table 20: Brazil gdp (current prices, $ billion), 2015-19
- Table 21: Brazil inflation, 2015-19
- Table 22: Brazil consumer price index (absolute), 2015-19
- Table 23: Brazil exchange rate, 2015-19
- Table 24: China pharmaceuticals market value: $ billion, 2015-19
- Table 25: China pharmaceuticals market geography segmentation: $ billion, 2019
- Table 26: China pharmaceuticals market share: % share, by value, 2019
- Table 27: China pharmaceuticals market value forecast: $ billion, 2019-24
- Table 28: China size of population (million), 2015-19
- Table 29: China gdp (constant 2005 prices, $ billion), 2015-19
- Table 30: China gdp (current prices, $ billion), 2015-19
- Table 31: China inflation, 2015-19
- Table 32: China consumer price index (absolute), 2015-19
- Table 33: China exchange rate, 2015-19
- Table 34: India pharmaceuticals market value: $ billion, 2015-19
- Table 35: India pharmaceuticals market geography segmentation: $ billion, 2019
- Table 36: India pharmaceuticals market share: % share, by value, 2019
- Table 37: India pharmaceuticals market value forecast: $ billion, 2019-24
- Table 38: India size of population (million), 2015-19
- Table 39: India gdp (constant 2005 prices, $ billion), 2015-19
- Table 40: India gdp (current prices, $ billion), 2015-19
- Table 41: India inflation, 2015-19
- Table 42: India consumer price index (absolute), 2015-19
- Table 43: India exchange rate, 2015-19
- Table 44: Mexico pharmaceuticals market value: $ billion, 2015-19
- Table 45: Mexico pharmaceuticals market geography segmentation: $ billion, 2019
- Table 46: Mexico pharmaceuticals market share: % share, by value, 2019
- Table 47: Mexico pharmaceuticals market value forecast: $ billion, 2019-24
- Table 48: Mexico size of population (million), 2015-19
- Table 49: Mexico gdp (constant 2005 prices, $ billion), 2015-19
- Table 50: Mexico gdp (current prices, $ billion), 2015-19
- Table 51: Mexico inflation, 2015-19
- Table 52: Mexico consumer price index (absolute), 2015-19
- Table 53: Mexico exchange rate, 2015-19
- Table 54: Adcock Ingram Holdings Ltd: key facts
- Table 55: Adcock Ingram Holdings Ltd: Annual Financial Ratios
- Table 56: Adcock Ingram Holdings Ltd: Key Employees
- Table 57: Aspen Pharmacare Holdings Ltd: key facts
- Table 58: Aspen Pharmacare Holdings Ltd: Annual Financial Ratios
- Table 59: Aspen Pharmacare Holdings Ltd: Key Employees
- List of Figures
- Figure 1: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2015-24
- Figure 2: Top 5 emerging countries pharmaceuticals industry, revenue ($bn), 2015-19
- Figure 3: Top 5 emerging countries pharmaceuticals industry forecast, revenue ($bn), 2019-24
- Figure 4: South Africa pharmaceuticals market value: $ billion, 2015-19
- Figure 5: South Africa pharmaceuticals market geography segmentation: % share, by value, 2019
- Figure 6: South Africa pharmaceuticals market share: % share, by value, 2019
- Figure 7: South Africa pharmaceuticals market value forecast: $ billion, 2019-24
- Figure 8: Forces driving competition in the pharmaceuticals market in South Africa, 2019
- Figure 9: Drivers of buyer power in the pharmaceuticals market in South Africa, 2019
- Figure 10: Drivers of supplier power in the pharmaceuticals market in South Africa, 2019
- Figure 11: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Africa, 2019
- Figure 12: Factors influencing the threat of substitutes in the pharmaceuticals market in South Africa, 2019
- Figure 13: Drivers of degree of rivalry in the pharmaceuticals market in South Africa, 2019
- Figure 14: Brazil pharmaceuticals market value: $ billion, 2015-19
- Figure 15: Brazil pharmaceuticals market geography segmentation: % share, by value, 2019
- Figure 16: Brazil pharmaceuticals market share: % share, by value, 2019
- Figure 17: Brazil pharmaceuticals market value forecast: $ billion, 2019-24
- Figure 18: Forces driving competition in the pharmaceuticals market in Brazil, 2019
- Figure 19: Drivers of buyer power in the pharmaceuticals market in Brazil, 2019
- Figure 20: Drivers of supplier power in the pharmaceuticals market in Brazil, 2019
- Figure 21: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2019
- Figure 22: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2019
- Figure 23: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2019
- Figure 24: China pharmaceuticals market value: $ billion, 2015-19
- Figure 25: China pharmaceuticals market geography segmentation: % share, by value, 2019
- Figure 26: China pharmaceuticals market share: % share, by value, 2019
- Figure 27: China pharmaceuticals market value forecast: $ billion, 2019-24
- Figure 28: Forces driving competition in the pharmaceuticals market in China, 2019
- Figure 29: Drivers of buyer power in the pharmaceuticals market in China, 2019
- Figure 30: Drivers of supplier power in the pharmaceuticals market in China, 2019
- Figure 31: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2019
- Figure 32: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2019
- Figure 33: Drivers of degree of rivalry in the pharmaceuticals market in China, 2019
- Figure 34: India pharmaceuticals market value: $ billion, 2015-19
- Figure 35: India pharmaceuticals market geography segmentation: % share, by value, 2019
- Figure 36: India pharmaceuticals market share: % share, by value, 2019
- Figure 37: India pharmaceuticals market value forecast: $ billion, 2019-24
- Figure 38: Forces driving competition in the pharmaceuticals market in India, 2019
- Figure 39: Drivers of buyer power in the pharmaceuticals market in India, 2019
- Figure 40: Drivers of supplier power in the pharmaceuticals market in India, 2019
- Figure 41: Factors influencing the likelihood of new entrants in the pharmaceuticals market in India, 2019
- Figure 42: Factors influencing the threat of substitutes in the pharmaceuticals market in India, 2019
- Figure 43: Drivers of degree of rivalry in the pharmaceuticals market in India, 2019
- Figure 44: Mexico pharmaceuticals market value: $ billion, 2015-19
- Figure 45: Mexico pharmaceuticals market geography segmentation: % share, by value, 2019
- Figure 46: Mexico pharmaceuticals market share: % share, by value, 2019
- Figure 47: Mexico pharmaceuticals market value forecast: $ billion, 2019-24
- Figure 48: Forces driving competition in the pharmaceuticals market in Mexico, 2019
- Figure 49: Drivers of buyer power in the pharmaceuticals market in Mexico, 2019
- Figure 50: Drivers of supplier power in the pharmaceuticals market in Mexico, 2019
- Figure 51: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Mexico, 2019
- Figure 52: Factors influencing the threat of substitutes in the pharmaceuticals market in Mexico, 2019
- Figure 53: Drivers of degree of rivalry in the pharmaceuticals market in Mexico, 2019